Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 93 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 8030317

    MAPK/ERK kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  2. US 8030488

    Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  3. US 8030307

    Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 protease

    Enanta Pharmaceuticals, Inc. · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  4. US 8026347

    Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors

    LEXICON PHARMACEUTICALS, INC. · Granted Sep 27, 2011 · Expires Sep 22, 2031

    granted

  5. US 8026360

    Substituted pyridazines as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Sep 27, 2011 · Expires Sep 22, 2031

    granted

  6. US 8026234

    Polo-like kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 27, 2011 · Expires Sep 22, 2031

    granted

  7. US 8022041

    Prodrug of an ICE inhibitor

    Vertex Pharmaceuticals Incorporated · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  8. US 8022202

    Dihydrodiazepines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  9. US 8022057

    MAPK/ERK kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  10. US 8017619

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  11. US 8017781

    Azaindazoles useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  12. US 8013015

    Small molecule inhibitors of ghrelin O-acyltransferase

    The Board of Regents of the University of Texas System · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  13. US 8012965

    Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  14. US 8012976

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

    BIOMARIN PHARMACEUTICAL INC. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  15. US 8008510

    Metalloprotein inhibitors

    The Regents of the University of California · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  16. US 7998987

    Inhibitors of c-Met and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  17. US 7998992

    Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1

    Institute of Medicinal Molecular Design, Inc. · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  18. US 7994205

    Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  19. US 7994326

    Potent and highly selective heteroaromatic inhibitors of neuronal nitric oxide synthase

    Northwestern University · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  20. US 7989498

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  21. US 7989456

    Pyrazine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  22. US 7985762

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted Jul 26, 2011 · Expires Jul 21, 2031

    granted

  23. US 7982037

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  24. US 7981936

    Crystalline ACAT inhibitor

    Graceway Pharmaceuticals. LLC · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.